Last reviewed · How we verify
NCT05221788
Effect of Goal-directed Hemodynamic Therapy on Short-term Postoperative Complications in Patients With Extensive Burns
NA trial testing Goal-directed hemodynamic therapy in Hemodynamics in 100 participants. Completed in 1 December 2021.
1 December 2021
Quick facts
| Lead sponsor | Guangzhou Red Cross Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 100 |
| Start date | 1 January 2020 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Goal-directed hemodynamic therapy — full drug profile →
Conditions studied
- Hemodynamics — all drugs for Hemodynamics →
Sponsor
Guangzhou Red Cross Hospital
Who can join
Adults 18 to 65, any sex, with Hemodynamics. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the effect of goal-directed hemodynamic management on perfusion and short-term prognosis of patients undergoing scab grafting in early stage of extensive burns.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect Of Goal-Directed Haemodynamic Therapy On Short-Term Postoperative Complications In Patients With Extensive Burns: A Single-Centre Randomised Controlled Trial
Liang B, Cai L, Cao Y, Huang H, et al · · 2022 · DOI 10.21203/rs.3.rs-1341626/v1
Verify or expand the search:
- PubMed search for NCT05221788
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Goal-directed hemodynamic therapy
Trials testing the same drug.
- NCT04517409 — Goal-directed Hemodynamic Therapy in Patiens Undergoing Major Hepatic Resection · NA · completed
Other recruiting trials for Hemodynamics
Currently open trials in the same condition.
- NCT07343843 — Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes Duri · NA · recruiting
- NCT07271849 — Nalbuphine Timing Effects on Hemodynamics and Analgesia in Elderly Patients · Phase 4 · recruiting
- NCT07260890 — Paired Comparison of SVV and PVI Accuracy · recruiting
- NCT07089173 — The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction Wit · NA · recruiting
- NCT07053605 — Clinical Study on Laparoscopic Resection of Splenic Artery Aneurysm With Preservation of Spleen · NA · recruiting
Other Guangzhou Red Cross Hospital trials
Trials by the same sponsor.
- NCT05241912 — Supernormal Oxygen Delivery for Patients With Severe Burns · EARLY_PHASE1 · unknown
- NCT04934761 — Study on the Effect of Capacity Shock Intervention Under Goal-directed Hemodynamic Management on P-V Loop · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05221788 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangzhou Red Cross Hospital
- Last refreshed: 3 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05221788.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing